Grant

Double Your Funding: The Guide to NSF SBIR Phase II Supplements (Phase IIB & TECP)

A comprehensive guide to securing up to $500,000 in additional non-dilutive funding for active NSF SBIR Phase II awardees through Phase IIB and TECP supplements.

JJ Ben-Joseph
JJ Ben-Joseph
💰 Funding Up to $500,000 (Phase IIB) + 20% of Award (TECP)
📅 Deadline Rolling (Based on Phase II Award Date)
📍 Location United States
🏛️ Source National Science Foundation
Apply Now

Double Your Funding: The Guide to NSF SBIR Phase II Supplements

Congratulations. You have won an NSF SBIR Phase II award. You have secured ~$1 million to build your deep-tech prototype. But as any hardware or biotech founder knows, $1 million doesn’t go as far as it used to. You need more runway to reach commercialization.

Enter the NSF Phase II Supplements.

Many founders treat the Phase II award as a fixed pot of money. This is a mistake. The NSF offers several “supplemental” funding mechanisms that can add hundreds of thousands of dollars to your grant, completely equity-free. The most powerful of these are the Phase IIB (matching funds) and TECP (Technology Enhancement for Commercial Partnerships).

Think of these not as new grants, but as “power-ups” for your existing award. They are designed to bridge the gap between your R&D and your first real sales.

Key Details at a Glance

DetailPhase IIB (The Match)TECP (The Partner)
Max AmountUp to $500,000 (1:2 match)20% of Phase II Award (~$200k)
TriggerThird-party investmentCorporate partnership/customer
Equity0% (Non-dilutive)0% (Non-dilutive)
Deadline18-24 months into Phase II6-18 months into Phase II
Success RateHigh (if eligibility met)High (if partner is strong)

The “Big One”: Phase IIB Matching Funds

The Phase IIB supplement is arguably the best deal in the entire startup ecosystem. The NSF will match 50 cents for every dollar of investment you raise, up to $500,000.

If you raise $1 million from a VC, angel, or strategic partner, the NSF gives you another $500,000. This means a $1 million round becomes a $1.5 million round, with zero additional dilution.

How It Works

The goal of Phase IIB is to incentivize private investors. You can tell a potential investor: “If you invest $1M, the government effectively de-risks your investment by adding $500k of non-dilutive capital on top.” This is a powerful closing tool.

Eligibility & Timing

  • Window: You typically apply between month 12 and month 24 of your Phase II award.
  • The Match: The minimum investment to trigger a match is $100,000 (getting you $50,000). The maximum match is $500,000 (requiring $1M+ investment).
  • Qualifying Investors: VCs, angel groups, and strategic corporate partners count. Friends and family usually do not. Revenue from sales does not count for Phase IIB (though it helps your case).

The “Strategic One”: TECP

TECP (Technology Enhancement for Commercial Partnerships) is different. It is not about matching dollars; it is about matching specs.

Often, you build a prototype that works perfectly, but a potential customer says, “This is great, but we need it to work at -40°C,” or “We need it to interface with our proprietary legacy system.”

TECP provides up to 20% of your original Phase II award (usually ~$200,000) to do that specific additional R&D.

How It Works

You need a letter from a commercial partner (a potential customer, distributor, or acquirer) stating:

  1. They are interested in your tech.
  2. There is a specific technical gap preventing them from buying/licensing it right now.
  3. If you fix that gap, they intend to move forward.

The NSF then pays you to fix that gap. It is essentially free money to customize your product for your first big customer.

Insider Tips for Winning Supplements

1. Treat Your Program Director (PD) as a Partner Unlike the blind peer review of Phase I, supplements are largely at the discretion of your Program Director. Talk to them early. Six months before you plan to apply, send an email: “We are in talks with Investor X and Customer Y. We are targeting a Phase IIB submission in November.” Get their buy-in before you write a single page.

2. The “Qualifying Investment” Trap For Phase IIB, the investment must be “arms-length.” If your rich uncle or a shell company you control puts in the money, the NSF will reject it. The investment must be validated by a term sheet and bank transfer. Convertible notes and SAFEs are generally accepted, but check the latest solicitation details.

3. Stack Them (Carefully) You can theoretically get both a Phase IIB and a TECP supplement, though usually not at the exact same time. A common strategy is to use TECP in Year 1 to nail a pilot with a corporate partner, and then use that pilot success to raise a VC round in Year 2, triggering the Phase IIB match.

4. Don’t Wait Until the Last Minute These supplements must be awarded before your Phase II grant expires. If your grant ends on December 31st, do not submit your request on December 1st. The NSF needs 3-6 months to process these. Submit at least 6 months before your grant expiration date.

Application Process

The application for supplements is much simpler than the original Phase II proposal.

For Phase IIB:

  1. Secure the Investment: Get the money in the bank or a signed commitment.
  2. Submit the Financial Package: You will upload proof of funds, the investor’s executive summary, and a simplified commercialization plan.
  3. Review: The NSF reviews the validity of the investor and the commercial potential.

For TECP:

  1. Get the Letter: Secure a letter of commitment from your commercial partner detailing the specific technical requirements.
  2. Write the Proposal: A short (5-10 page) description of the additional R&D tasks.
  3. Submit: Upload via Research.gov as a “Supplemental Funding Request.”

Common Mistakes to Avoid

1. Letting the Clock Run Out The most common reason for rejection is timing. If your Phase II grant expires, you are no longer eligible for supplements. You must request a “No-Cost Extension” if you are running out of time, but even then, some supplements have strict windows based on the original start date.

2. Vague Partner Letters For TECP, a letter saying “We support this company” is useless. It must say “We need Feature X, Y, and Z to consider purchasing.” Specificity gets funded.

3. Ignoring the “R” in R&D TECP funds must be used for Research. You cannot use them for marketing, sales travel, or legal fees. You must describe the technical work you will do to meet the partner’s needs.

Frequently Asked Questions

Q: Does the Phase IIB match take equity? A: No. It is a grant. The investor gets equity for their $1M; the NSF gives you $500k for free.

Q: Can I use sales revenue for the Phase IIB match? A: Generally, no. Phase IIB is designed to leverage investment capital. However, significant revenue is a huge plus for your commercialization plan.

Q: What if my investor is outside the US? A: This is tricky. The NSF prefers US-based investors. Foreign investment triggers strict scrutiny regarding national security and IP leakage. Consult your PD immediately if your lead investor is non-US.

Q: Can I apply for Phase IIB multiple times? A: Usually, you get one shot at the Phase IIB match per Phase II award. Make it count. Don’t apply with a $200k investment if you think you can raise $1M six months later.

How to Apply

These opportunities are not listed on a public job board. They are managed through the Research.gov portal associated with your existing award.

  1. Login: Go to Research.gov.
  2. Navigate: Go to “Awards & Reporting” -> “Supplemental Funding Request.”
  3. Select: Choose your active Phase II award and the type of supplement (Phase IIB or TECP).

Official Guidelines: NSF Phase II Supplement Guide